Add to MyYahoo RSS

Humalog, Insulin Lispro News

News on Humalog, Insulin Lispro (generic) continually updated from thousands of sources around the net.

Yesterday | BioSpace

Adocia Announces Approval To Start A Phase IIa Clinical Study Of...

HinsBet's objective is to improve human insulin performance in a cost-effective way Phase IIa study will compare HinsBet to a fast-acting insulin analog and a regular human insulin in type 1 diabetic patients First Patient In planned for the first week of August Lyon, France, July 9th, 2014 - Adocia announced today that BfArM , the German ... (more)


Related Topix: Medicine, Insulin (generic), Humulin, Novolin, Adocia, France, World News,

Mon Jun 30, 2014

The Motley Fool

MannKind Stock: Afrezza Approved at Last, But Will Sales Disappoint?

Approval is a major event for MannKind, but the company still needs a commercial partner and the approved label for Afrezza doesn't do the product/company any particular favors.


Related Topix: Healthcare Law, Law, Medicine, Insulin (generic), Humulin, Novolin, Advanced Bionics, Medical Equipment, Healthcare Industry, Health, Lung Cancer, Diabetes

Fri Jun 27, 2014


UPDATE 3-U.S. FDA approves MannKind's inhaled insulin, Afrezza

The U.S. Food and Drug Administration said on Friday it has approved MannKind Corp's inhaled insulin, Afrezza, capping an arduous journey for the company and its octogenarian founder, Alfred Mann.


Related Topix: Food and Drug Administration, Biotech, MannKind, Medicine, Insulin (generic), Humulin, Novolin, Diabetes, Health, Lung Cancer

Wed Jun 18, 2014

Medical News Today

Lilly announces detailed results from two Phase III studies testing...

Eli Lilly and Company has released detailed results from two AWARD trials that showed treatment with once-weekly dulaglutide 1.5 mg resulted in superior reductions in HbA1c from baseline compared to insulin glargine, with a lower risk for hypoglycemia .1,2 Dulaglutide is an investigational glucagon-like peptide-1 receptor agonist being studied for ... (more)


Related Topix: Medicine, Lantus, Insulin Glargine (generic), Biotech, Eli Lilly, Healthcare Industry, Diabetes, Health, Italy, World News, Insulin (generic), Humulin, Novolin

Mon Jun 16, 2014

Applied Clinical Trials

Lilly Announces Detailed Results from Two Phase III Studies Testing...

Results were presented at the 74th American Diabetes Association Scientific Sessions in San Francisco.


Related Topix: Biotech, Medicine, Eli Lilly, Healthcare Industry, Lantus, Insulin Glargine (generic), Diabetes, Health, Insulin (generic), Humulin, Novolin